Royal Bank of Canada’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46M | Buy |
172,669
+165,071
| +2,173% | +$7.13M | ﹤0.01% | 2043 |
|
|
2025
Q1 | $263K | Sell |
7,598
-5,836
| -43% | -$202K | ﹤0.01% | 4160 |
|
|
2024
Q4 | $368K | Sell |
13,434
-6,871
| -34% | -$188K | ﹤0.01% | 3877 |
|
|
2024
Q3 | $517K | Buy |
20,305
+1,613
| +9% | +$41.1K | ﹤0.01% | 3664 |
|
|
2024
Q2 | $473K | Buy |
18,692
+11,564
| +162% | +$293K | ﹤0.01% | 3697 |
|
|
2024
Q1 | $221K | Sell |
7,128
-32,879
| -82% | -$1.02M | ﹤0.01% | 4181 |
|
|
2023
Q4 | $1.62M | Buy |
40,007
+20,748
| +108% | +$838K | ﹤0.01% | 2798 |
|
|
2023
Q3 | $507K | Sell |
19,259
-2,042
| -10% | -$53.8K | ﹤0.01% | 3556 |
|
|
2023
Q2 | $367K | Sell |
21,301
-5,953
| -22% | -$103K | ﹤0.01% | 3792 |
|
|
2023
Q1 | $452K | Buy |
27,254
+7,010
| +35% | +$116K | ﹤0.01% | 3594 |
|
|
2022
Q4 | $153K | Buy |
20,244
+6,098
| +43% | +$46.1K | ﹤0.01% | 4651 |
|
|
2022
Q3 | $141K | Sell |
14,146
-6,660
| -32% | -$66.4K | ﹤0.01% | 4583 |
|
|
2022
Q2 | $189K | Buy |
20,806
+100
| +0.5% | +$908 | ﹤0.01% | 4394 |
|
|
2022
Q1 | $210K | Sell |
20,706
-12,462
| -38% | -$126K | ﹤0.01% | 4571 |
|
|
2021
Q4 | $553K | Buy |
33,168
+24,523
| +284% | +$409K | ﹤0.01% | 3871 |
|
|
2021
Q3 | $405K | Sell |
8,645
-496
| -5% | -$23.2K | ﹤0.01% | 4043 |
|
|
2021
Q2 | $557K | Sell |
9,141
-117
| -1% | -$7.13K | ﹤0.01% | 3743 |
|
|
2021
Q1 | $570K | Buy |
9,258
+7,999
| +635% | +$492K | ﹤0.01% | 3632 |
|
|
2020
Q4 | $89K | Buy |
+1,259
| New | +$89K | ﹤0.01% | 4859 |
|
|
2020
Q3 | – | Sell |
-69
| Closed | -$2K | – | 6101 |
|
|
2020
Q2 | $2K | Sell |
69
-282
| -80% | -$8.17K | ﹤0.01% | 5787 |
|
|
2020
Q1 | $10K | Sell |
351
-887
| -72% | -$25.3K | ﹤0.01% | 5322 |
|
|
2019
Q4 | $43K | Buy |
1,238
+1,084
| +704% | +$37.7K | ﹤0.01% | 4925 |
|
|
2019
Q3 | $3K | Buy |
+154
| New | +$3K | ﹤0.01% | 5520 |
|